{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:39:30Z","timestamp":1788406770440,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Daewon Pharmaceutical Co Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Propofol formulated with medium- and long-chain triglycerides (MCT\/LCT propofol) has rapidly replaced propofol formulated with long-chain triglycerides (LCT propofol). Despite this shift, the modified Marsh and Schnider pharmacokinetic models developed using LCT propofol are still widely used for target-controlled infusion (TCI) of propofol. This study aimed to validate the external applicability of these models by evaluating their predictive performance during TCI of MCT\/LCT propofol in general anesthesia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adult patients (<jats:italic>n<\/jats:italic>\u2009=\u200948) undergoing elective surgery received MCT\/LCT propofol via a TCI system using either the modified Marsh or Schnider models. Blood samples were collected at various target propofol concentrations and at specific time points, including the loss of consciousness and the recovery of consciousness (13 samples per patient). The actual plasma concentration of propofol was determined using high-performance liquid chromatography. The predictive performance of each pharmacokinetic model was assessed by calculating four parameters: inaccuracy, bias, divergence, and wobble.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both the modified Marsh and Schnider models demonstrated predictive performances within clinically acceptable ranges for MCT\/LCT propofol. The inaccuracy values were 24.4% for the modified Marsh model and 26.9% for the Schnider model. Both models showed an overall positive bias, 16.4% for the modified Marsh model and 16.6% for the Schnider model. The predictive performance of MCT\/LCT propofol was comparable to that of LCT propofol, suggesting formulation changes might exert only a minor impact on the reliability of the TCI system during general anesthesia. Additionally, both models exhibited higher bias and inaccuracy at target concentrations ranging from 3.5\u2009~\u20095 ug\/ml than at concentrations between 2\u2009~\u20093 ug\/ml.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The modified Marsh and Schnider models, initially developed for LCT propofol, remain clinically acceptable for TCI with MCT\/LCT propofol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This study was registered at the Clinical Research Information Service of the Korean National Institute of Health (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/cris.nih.go.kr\">https:\/\/cris.nih.go.kr<\/jats:ext-link>; registration number: KCT0002191; 06\/01\/2017).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-024-02461-5","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T05:03:08Z","timestamp":1708664588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia"],"prefix":"10.1186","volume":"24","author":[{"given":"Seongheon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungah","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongwook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"4","key":"2461_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00000542-200510000-00026","volume":"103","author":"MT Baker","year":"2005","unstructured":"Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology. 2005;103(4):860\u201376.","journal-title":"Anesthesiology"},{"issue":"1","key":"2461_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.2042-7158.1998.tb03302.x","volume":"50","author":"S Dutta","year":"1998","unstructured":"Dutta S, Ebling WF. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. J Pharm Pharmacol. 1998;50(1):37\u201342.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2461_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1023\/A:1011980432646","volume":"15","author":"EH Cox","year":"1998","unstructured":"Cox EH, Knibbe CA, Koster VS, Langemeijer MW, Tukker EE, Lange R, et al. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. Pharm Res. 1998;15(3):442\u20138.","journal-title":"Pharm Res"},{"issue":"5","key":"2461_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/01.anes.0000265151.78943.af","volume":"106","author":"KM Kim","year":"2007","unstructured":"Kim KM, Choi BM, Park SW, Lee SH, Christensen LV, Zhou J, et al. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion. Anesthesiology. 2007;106(5):924\u201334.","journal-title":"Anesthesiology"},{"issue":"6","key":"2461_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/00000542-200212000-00011","volume":"97","author":"DS Ward","year":"2002","unstructured":"Ward DS, Norton JR, Guivarc\u2019h PH, Litman RS, Bailey PL. Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion. Anesthesiology. 2002;97(6):1401\u20138.","journal-title":"Anesthesiology"},{"issue":"6","key":"2461_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1213\/00000539-199712000-00040","volume":"85","author":"AW Doenicke","year":"1997","unstructured":"Doenicke AW, Roizen MF, Rau J, O\u2019Connor M, Kugler J, Klotz U, et al. Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg. 1997;85(6):1399\u2013403.","journal-title":"Anesth Analg"},{"issue":"2","key":"2461_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/01.anes.0000435741.97234.04","volume":"120","author":"M Le Guen","year":"2014","unstructured":"Le Guen M, Grassin-Delyle S, Cornet C, Genty A, Chazot T, Dardelle D, et al. Comparison of the potency of different propofol formulations: a randomized, double-blind trial using closed-loop administration. Anesthesiology. 2014;120(2):355\u201364.","journal-title":"Anesthesiology"},{"issue":"1","key":"2461_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/bja\/aep143","volume":"103","author":"AR Absalom","year":"2009","unstructured":"Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol\u2013defining and illuminating the devil in the detail. Br J Anaesth. 2009;103(1):26\u201337.","journal-title":"Br J Anaesth"},{"issue":"1","key":"2461_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF01143186","volume":"20","author":"JR Varvel","year":"1992","unstructured":"Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm. 1992;20(1):63\u201394.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"5","key":"2461_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/bja\/aep043","volume":"102","author":"JB Glen","year":"2009","unstructured":"Glen JB, Servin F. Evaluation of the predictive performance of four pharmacokinetic models for propofol. Br J Anaesth. 2009;102(5):626\u201332.","journal-title":"Br J Anaesth"},{"issue":"6","key":"2461_CR11","first-page":"1275","volume":"81","author":"J Vuyk","year":"1995","unstructured":"Vuyk J, Engbers FH, Burm AG, Vletter AA, Bovill JG. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets. Anesth Analg. 1995;81(6):1275\u201382.","journal-title":"Anesth Analg"},{"issue":"Suppl","key":"2461_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2044.1988.tb09059.x","volume":"43","author":"J Schuttler","year":"1988","unstructured":"Schuttler J, Kloos S, Schwilden H, Stoeckel H. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia. 1988;43(Suppl):2\u20137.","journal-title":"Anaesthesia"},{"issue":"2","key":"2461_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/bja\/aeg046","volume":"90","author":"MJ Mertens","year":"2003","unstructured":"Mertens MJ, Engbers FH, Burm AG, Vuyk J. Predictive performance of computer-controlled infusion of remifentanil during propofol\/remifentanil anaesthesia. Br J Anaesth. 2003;90(2):132\u201341.","journal-title":"Br J Anaesth"},{"issue":"1","key":"2461_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1213\/ANE.0000000000001005","volume":"122","author":"TW Schnider","year":"2016","unstructured":"Schnider TW, Minto CF, Struys MM, Absalom AR. The safety of target-controlled infusions. Anesth Analg. 2016;122(1):79\u201385.","journal-title":"Anesth Analg"},{"issue":"6","key":"2461_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/anae.12631","volume":"69","author":"JB Glen","year":"2014","unstructured":"Glen JB, White M. A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion. Anaesthesia. 2014;69(6):550\u20137.","journal-title":"Anaesthesia"},{"issue":"3","key":"2461_CR16","first-page":"472","volume":"82","author":"AW Doenicke","year":"1996","unstructured":"Doenicke AW, Roizen MF, Rau J, Kellermann W, Babl J. Reducing pain during propofol injection: the role of the solvent. Anesth Analg. 1996;82(3):472\u20134.","journal-title":"Anesth Analg"},{"issue":"5","key":"2461_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1021\/bi00457a006","volume":"29","author":"RJ Deckelbaum","year":"1990","unstructured":"Deckelbaum RJ, Hamilton JA, Moser A, Bengtsson-Olivecrona G, Butbul E, Carpentier YA, et al. Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry. 1990;29(5):1136\u201342.","journal-title":"Biochemistry"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02461-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T05:03:17Z","timestamp":1708664597000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02461-5","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Chonnam National University Hwasun Hospital (IRB no. CNUHH-2014\u2013101). Written informed consent was obtained from all participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}